Posts

Commure acquires Elaborate to automate clinicians’ inbox work

Commure announced on November 16, 2026, that it acquired Elaborate, a clinical-intelligence company focused on reducing doctors’ patient-inbox workload. Elaborate’s software works inside electronic health records: it helps patients find answers before messaging, routes incoming messages to the appropriate care team, and automates selected clinical workflows using protocols set by clinicians. Commure says health systems using Elaborate have seen up to 36% less time in the inbox, 15% fewer patient messages, and 97% clinician alignment with automation. Those figures are company-reported, not independently verified. The financial terms were not disclosed. Commure says Elaborate is available to health systems and medical practices, either on its own or alongside Commure’s other products. The acquisition expands Commure’s healthcare AI platform beyond tasks such as documentation, coding, and revenue-cycle workflows to include post-visit patient messages. Sources: Commure Acquir...

Regeneron enters neurology with FDA approval of Livsayis for myasthenia gravis

FDA approves Sanofi’s Infilbray as first treatment for Type 3 Gaucher neurological symptoms

AbbVie and DISCO strike solid-tumor research deal worth up to $2.54B

nChroma halts hepatitis B trial and cuts workforce by about half

Jefferies biotech dispatch: AI, PI3Kα and protein degraders

Merck ends development of ArQule’s blood cancer drug

FDA rejects Summit’s ivonescimab application, citing modest benefit and added risks

Pfizer enters in vivo CAR-T with up to $2.6 billion Starna deal

GSK wins FDA approval for second Nuvalent lung cancer drug

CTAD 2026: Biogen and AriBio report signals of slower cognitive decline

Marrow raises $173 million to develop an siRNA approach for sickle cell disease

SELLAS reports Phase 3 survival benefit for investigational AML vaccine